V E Steele
About
In The Last Decade
V E Steele
6 papers receiving 380 citations
Peers
Comparison fields: 5 of 65
- Genetics 165
- Pharmacology 159
- Molecular Biology 116
- Cancer Research 73
- Oncology 66
Countries citing papers authored by V E Steele
This map shows the geographic impact of V E Steele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V E Steele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V E Steele more than expected).
Fields of papers citing papers by V E Steele
This network shows the impact of papers produced by V E Steele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V E Steele. The network helps show where V E Steele may publish in the future.
Co-authorship network of co-authors of V E Steele
This figure shows the co-authorship network connecting the top 25 collaborators of V E Steele. A scholar is included among the top collaborators of V E Steele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V E Steele. V E Steele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Response of rosiglitazone, UAB 30, and atorvastatin in the human melanoma prevention assayl. | 1 |
| 2 | A quantitative angiogenesis model for efficacy testing of chemopreventive agents. | 28 |
| 3 | Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. | 219 |
| 4 | Aromatase inhibitors as potential cancer chemopreventives. | 58 |
| 5 | Modulation of methylnitrosourea-induced breast cancer in Sprague Dawley rats by dehydroepiandrosterone: dose-dependent inhibition, effects of limited exposure, effects on peroxisomal enzymes, and lack of effects on levels of Ha-Ras mutations. | 37 |
| 6 | Surrogate endpoint biomarkers for phase II cancer chemoprevention trials. | 49 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.